Your browser doesn't support javascript.
loading
The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer.
Horlock, C; Stott, B; Dyson, P J; Morishita, M; Coombes, R C; Savage, P; Stebbing, J.
Affiliation
  • Horlock C; Department of Oncology, Imperial College School of Medicine, Hammersmith Hospital Campus, London, UK.
Br J Cancer ; 100(7): 1061-7, 2009 Apr 07.
Article in En | MEDLINE | ID: mdl-19277040
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / CD4-Positive T-Lymphocytes / T-Lymphocytes, Regulatory / Interleukin-17 / Forkhead Transcription Factors / Antibodies, Monoclonal / Antineoplastic Agents Limits: Adult / Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2009 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / CD4-Positive T-Lymphocytes / T-Lymphocytes, Regulatory / Interleukin-17 / Forkhead Transcription Factors / Antibodies, Monoclonal / Antineoplastic Agents Limits: Adult / Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2009 Document type: Article Affiliation country: Country of publication: